Blog FDA approves Keytruda combo for first-line lung cancer treatment May 12, 2017December 14, 2022 Arthur N. Brodsky, PhD
Blog Pembrolizumab (Keytruda®) Approved as First-Line Option for Lung Cancer October 25, 2016December 14, 2022 Arthur N. Brodsky, PhD
Blog FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer August 8, 2016December 14, 2022 Alexandra Mulvey
Blog European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
Blog How Immunotherapy Fights Breast Cancer Through Personalized Treatment October 9, 2024November 1, 2024 Max Mallet
